Dr Riyaz Shah· @DrRiyazShah · X·· 4 小时前评分70
正文 · 原文
HERON-lung01; Ruzaltatug rezetecan (will we call this Ruiz-Rez is my overriding thought?) in common mEGFR; n498; mPFS HR 0.47 -3m longer ; mDOR 8.5m ; tolerability looks somewhat more palatable than izabren? #ESMO26
19 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA13按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)
https://esmocongress.esmo.org来源：Dr Riyaz Shah · x.com